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ABSTRACT
Alternative pre-mRNA splicing (AS) is a major mech-
anism that allows proteomic variability in eukaryotic
cells. However, many AS events result in mRNAs
containing a premature termination codon, which
are degraded by nonsense-mediated mRNA decay
(NMD) pathway. We have previously demonstrated
that human rpL3 autoregulates its expression
through the association of AS with NMD. In fact,
overexpression of rpL3 promotes downregulation
of canonical splicing and upregulation of alternative
splicing that produces an NMD-targeted mRNA
isoform. The result of these events is a decreased
production of rpL3. We have also identified hetero-
geneous nuclear ribonucleoprotein (hnRNP) H1 as a
splicing factor involved in the regulation of rpL3 al-
ternative splicing and identified its regulatory cis-
elements within intron 3 transcript. Here, we report
that NPM and KHSRP are two newly identified
proteins involved in the regulation of rpL3 gene ex-
pression via AS-NMD. We demonstrate that hnRNP
H1, KHSRP and NPM can be found associated, and
present also in ribonucleoproteins (RNPs) including
rpL3 and intron 3 RNA in vivo, and describe protein–
protein and RNA–protein interactions. Moreover, our
data provide an insight on the crucial role of hnRNP
H1 in the regulation of the alternative splicing of the
rpL3 gene.
INTRODUCTION
Alternative splicing (AS) is an important mechanism of
gene expression control, through which an individual
gene gives rise to different mRNAs encoding distinct
proteins, thus allowing functional and genetic variability
(1). In addition to the canonical splice elements, auxiliary
non-splice site RNA sequences have been identiﬁed and
are located in both introns and exons. These additional
elements are needed for a proper splicing and regulation of
the process. They may function as enhancers or silencers
of the splicing reaction, and may inﬂuence recognition
and usage of the splice sites by the splicing apparatus
through the binding of speciﬁc regulatory proteins (2).
These proteins include members of the serine–
arginine-rich (SR) proteins, the heterogeneous nuclear
ribonucleoprotein (hnRNP) family and other RNA
binding proteins (3). The SR proteins represent a family
of highly conserved trans-acting factors that usually
induce splicing, whereas the hnRNP proteins can affect
the splicing depending on the interacting cis-elements
and on the gene context (4,5). Moreover, in some case,
the result of a splicing reaction is determined by the an-
tagonistic action of hnRNP and SR proteins since they are
able to recognize and bind to a composite regulatory
element generated by the overlapping of enhancer and
silencer elements (6).
AS can also control gene expression quantitatively by
generating unproductive mRNAs that are targeted for
degradation by nonsense-mediated decay (NMD) (7).
NMD is a surveillance pathway that detects and selective-
ly degrades aberrant mRNAs harboring a premature ter-
mination codon (PTC), thus preventing the production of
truncated polypeptides potentially deleterious to the cell.
NMD is highly conserved in eukaryotes; many studies
have dissected machinery components, and the issue of
its localization in a cell compartment has been thoroughly
discussed (8,9 and references therein). The process
regulating gene expression through AS-NMD association
has been deﬁned Regulated Unproductive Splicing and
Translation (RUST) (10).
Although the mechanisms of the AS have been exten-
sively studied, the complex regulation of such process is
still an issue. The complexity of the regulation pathways is
due to an intricate and dynamic network of protein–
protein and RNA–protein interactions. Changes in the
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activity, number and association of splicing factors in the
network can modify the selection of the splice site and
the activity of the splicing machinery, and therefore the
splicing pattern of the target pre-mRNA.
The regulation of pre-mRNA splicing plays an import-
ant role in human pathologies (11). Impairment of the AS
is closely related to some disease mechanisms as in the case
of spinal muscular atrophy and myotonic distrophy.
Recently, new therapies aimed to correct defects arising
in pre-mRNA splicing, the so-called ‘splice-correction’ or
‘splice-modulation’ therapies, have been developed (12).
The accuracy of the AS depends on the stoichiometry
and interactions of positive and negative regulatory
proteins. Consequently, the identiﬁcation of the proteins
participating in the modulation of the AS is an essential
step to study the many aspects of gene expression.
Data from several laboratories demonstrate that some
alternative isoforms of mRNA-encoding ribosomal
proteins (rp) are NMD substrates. In Caenorhabditis
elegans, it has been shown that the AS of genes rpL3,
rpL12, rpL10 and rpL7 gives rise to aberrant mRNA
isoforms, which contain a PTC resulting from an incom-
plete intron removal, and are natural substrate of NMD
(13). The AS event appears conserved in humans and in
other mammals on rpL3 and rpL12 genes. In fact, we have
previously demonstrated that human rpL3 gene transcript
gives rise to a canonical mRNA and to an alternative
mRNA isoform containing a PTC targeted to decay by
NMD. rpL3 is able to modulate its own production via a
negative feedback loop. In fact, rpL3 overexpression
results in a decreased level of the canonically spliced
mRNA, and an increased production of the alternatively
spliced isoform (14). We have also identiﬁed the hnRNP
H1, as a transacting factor able to interact in vitro and
in vivo with rpL3 and with intron 3 transcript of the rpL3
gene. Our data demonstrated that hnRNP H1 is involved
in promoting the AS of human rpL3 pre-mRNA. In
addition, we have identiﬁed and characterized the
cis-acting regulatory elements, G runs, involved in
hnRNP H1-mediated regulation of splicing (15). In the
present study, we analyze the role of hnRNP H1 in the
rpL3 autoregulatory loop, and we report the identiﬁcation
of two new regulatory proteins, KHSRP (K-homology
splicing regulatory protein, also known as KSRP) and
NPM (Nucleophosmin, also known as B23, numatrin or
NO38), which exhibit opposite effects on the splicing
reaction of rpL3 pre-mRNA. Our data contribute to
shed light on protein–protein and RNA–protein inter-
actions within putative RNP complexes involved in the
modulation of splicing of the rpL3 gene.
MATERIALS AND METHODS
Cell cultures, transfections and drug treatment
Human cell line HeLa was cultured in Dulbecco’s
Modiﬁed Eagle’s Medium (DMEM) with glutamax
(Invitrogen, Carlsbad, CA, USA) supplemented with
10% fetal bovine serum (FBS), 2mM L-glutamine and
penicillin–streptomycin 50U/ml.
L3–8 cell line, derived from rat PC12 Tet-Off cell line
and conditionally overexpressing rpL3 upon doxycyclin
removal (14), was grown in DMEM supplemented with
5% fetal calf serum (FCS), 10% horse serum, 2mM
L-glutamine and 100 mg/ml G418 (Invitrogen), hygromycin
200 mg/ml (USB, Santa Clara, CA, USA) and doxycyclin
10 ng/ml (Sigma, St Louis, MO, USA). The expression of
HA-rpL3 was induced upon removal of doxycyclin.
siRNA transfections were performed in HeLa cells
(1 106 cells, 6mm well plate) at a concentration of
150 nM by using Oligofectamine Reagent (Invitrogen) ac-
cording to the manufacturer’s instructions.
Plasmids were transfected in L3–8 cell line or in HeLa
cells (2.5 106 cells, 6mm well plate) by using
Lipofectamine 2000 (Invitrogen) according to the manu-
facturer’s instructions. Twenty-four hours after DNA or
siRNA transfections, cells were treated with 100 mg/ml
cycloheximide (CHX) for 4 h to block NMD. Then,
RNA and proteins were extracted by using the Trizol pro-
cedure (Invitrogen) for RT–PCR analysis and western
blot, respectively. Transfection efﬁciency was assessed by
cotransfecting a GFP-expressing vector and normalizing
RNA levels against GFP mRNA levels (data not shown).
DNA constructs and production of recombinant proteins
The cDNA of NPM was obtained by RT–PCR from
HeLa cells using the primers 50-ATGGAAGATTCGAT
GGAC-30 (forward) and 50-TTAAAGAGACTTCCTCC
A-30 (reverse), and cloned into a version of the eukaryotic
expression vector pcDNA4/HisMax C (Invitrogen) con-
taining the HA epitope, into the prokaryotic expression
vector pRSET-A (Invitrogen) containing the Histidine
tag, and in the prokaryotic expression vector pGEX4T3
(GE Healthcare, Waukesha, WI, USA). The cDNA of
hnRNP H1 was obtained by RT–PCR from HeLa cells
using the primers 50-ATGATGTTGGGCACGGAA-30
(forward) and 50-CTATGCAATGTTTGATTGAAAA-30
(reverse), and cloned into the prokaryotic expression
vector pRSET-A. The plasmids encoding GST-hnRNP
H1, GST-rpL3, HA-hnRNP H1, Flag-KHSRP and
pGEM4Z-Int3 were already available (15,16).
The recombinant proteins GST-hnRNP H1, GST-rpL3,
GST-rpL7a and GST were expressed in Escherichia coli
and puriﬁed by using glutathione Sepharose 4B beads
according to the manufacturer’s instructions (GE
Healthcare). The recombinant proteins His-NPM,
His-hnRNP H1 and His-rpL7a were expressed in E. coli
and puriﬁed by the nickel–nitrilotriacetic acid (Ni–NTA)-
Agarose chromatography according to the manufacturer’s
instructions (Qiagen, Valencia, California). His-tagged
KHSRP was expressed in Sf9 cells using the Baculovirus
system (Baculogold, BD Biosciences) and puriﬁed by
Ni–NTA-Agarose chromatography (16).
RNA interference
The target sequences of small interfering RNAs (siRNA)
in hnRNP H1 were: 50-GGAAATAGCTGAAAAGGC
T-30 and 50-CCACGAAAGCTTATGGCCA-30
(Ambion, Foster City, CA, USA). The siRNAs targeting
NPM and KHSRP were purchased from Santa Cruz
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Biotechnology (Santa Cruz Biotechnology, Santa Cruz,
CA, USA, sc-29771, sc-44831).
GST pull down
For GST pull-down assay, 50 mg of the fusion protein or
GST control, as bait were immobilized on glutathione-
Sepharose beads and incubated with 20 mg of the recom-
binant protein of interest in pull-down buffer (50mM
Tris–HCl, pH 7.5, 0.4mM EDTA, 150mM NaCl, 10%
glicerol, 1% NP-40, 1mM sodium-ortovanadate, 50mM
NaF, 5mM DTT and Protease Inhibitor Mix 1X) at 4C
for 1.5 h. The beads were washed extensively and boiled in
SDS sample buffer. The eluted proteins were loaded on
12% SDS–PAGE and analyzed by western blotting.
Immunoprecipitation and western blotting
For immunoprecipitation assay, 1mg of HeLa whole-cell
lysate was incubated with 30 ml of protein A/G agarose
beads coated with 5 mg of anti-NPM or anti-KHSRP
(Santa Cruz Biotechnology sc-47725, sc-33031) at 4C
for 12 h. The beads were washed and boiled in the SDS
sample buffer. The eluted proteins were loaded on 12%
SDS–PAGE and detected by western blotting. Aliquots of
protein samples (30 mg) were resolved by 12% SDS–gel
electrophoresis and transferred into nitrocellulose ﬁlters.
The membranes were blocked in PBS, 0.1% Triton and
5% dry milk for 2 h, and then challenged with anti-NPM,
anti-KHSRP, anti-hnRNP H1, anti-HA, anti-Flag (Santa
Cruz Biotechnology sc-10042, sc-57592 and sc-807) and
anti-rpL3 (Primm, Milan, Italy). The proteins were
visualized with enhanced chemiluminescence detection
reagent according to the manufacturer’s instructions
(Pierce, Rockford, IL, USA).
RNA pull-down assay
RNA pull-down assay was carried out by using adipic acid
dehydrazide beads. Brieﬂy, 20 mg of intron 3 RNA,
transcribed in vitro from pGEM4Z-Int3, were placed in
a 400 ml reaction mixture containing 100mM NaOAc
pH 5.2 and 5mM sodium m-periodate (Sigma), incubated
for 1 h in the dark at room temperature, ethanol
precipitated and resuspended in 100 ml of 100mM
NaOAc, pH 5.2. Then, 300ml of adipic acid dehydrazide
agarose beads 50% slurry (Sigma) equilibrated in 100mM
NaOAc pH 5.2 were added to this mixture, which was
then incubated for 12 h at 4C on a rotator. The beads
with the bound RNA were pelletted, washed twice with
1ml of 2M NaCl and equilibrated in washing buffer
(5mM HEPES pH 7.9, 1mM MgCl2, 0.8mM magnesium
acetate). The intron 3 RNA was then incubated with 50 mg
of each recombinant protein for 30min at room tempera-
ture in a ﬁnal volume of 0.6ml. The beads were then
washed four times in 1.5ml of washing buffer. Bound
proteins were eluted in SDS sample buffer loaded on a
12% gel for SDS–PAGE and analyzed by western
blotting.
RNP immunoprecipitation assay
For RNP immunoprecipitation assay (RIPA), HeLa cells
(2 106 cells) were lysed in 600 ml RIPA buffer 1 (10mM
Tris–HCl pH 7.5, 150mM NaCl, 0.1mM EDTA, 1mM
Na ortovanadate, 0.05M NaF, 0.5% NP-40) with
protease inhibitors mix 1 (Roche, Basel, Switzerland)
for 60min on ice, and then centrifuged at 10 000 g at
4C for 15min. The supernatant was subjected to a
pre-clearing step in which it was incubated with 50 ml of
protein A/G plus agarose for 1 h at 4C. The pre-cleared
cell extracts were then incubated with antibodies speciﬁc
for each protein (Santa Cruz Biotechnology) overnight at
4C. Protein A/G plus agarose beads (50 ml of 50% slurry)
were then added and the mix was incubated for 1 h at 4C
with gentle shaking and centrifuged. The immunopre-
cipitates were suspended in 100 ml TES buffer (10mM
Tris–HCl pH 7.5, 0.5mM EDTA, 0.5% SDS), incubated
at 65C for 10min and centrifuged for 1min at 10 000g.
Ten microliters of the supernatant were stored as
immunoprecipitated samples and subsequently
fractionated by SDS–PAGE to be analyzed by western
blotting. RNA was extracted from 90 ml using the Trizol
procedure (Invitrogen).
RT–PCR
For RT–PCR analysis, 1 mg of total RNA was reverse
transcribed into cDNA with the random hexamers tech-
nique using 200U of Superscript II RNAse H Reverse
Trancriptase (Invitrogen). The reaction was carried out at
42C for 50min and was terminated by heating to 75C
for 15min. Ten of the 40 ml of reaction mix were PCR
ampliﬁed in a ﬁnal volume of 50 ml, using 5 mM of each
speciﬁc primer, 10mM dNTPs and 0.5U of Taq DNA
polymerase (Invitrogen). Typically, 25–30 cycles of amp-
liﬁcation were performed. The primers were: rpL3-a 50-CT
CCGCTGGGCTCTGCCC-30 (forward) and 50-CTTCAG
GAGCAGAGCAGA-30 (reverse); rpL3-c 50-GGGCATT
GTGGGCTACGT 30 (forward) and 50-GTAAAGGCCT
TCTTCTTAG-30 (reverse); and b-actin 50-GGCACCACC
TTCTACA-30 (forward) and 50-CAGGAGGACAATGA
T-30 (reverse).
In separate experiments, we ascertained that the cycle
number was within the linear range of ampliﬁcations.
PCR products were visualized on 1% agarose gel con-
taining the ﬂuorescent Vistra Green dye (15). The
labeling intensity of the PCR product, which is linear to
the amount of DNA, was quantiﬁed using the
PhosphorImager (Bio-Rad, Haercules, CA, USA).
RESULTS
Interactions between NPM, KHSRP, hnRNP H1 and
rpL3 in vivo and in vitro
We have identiﬁed, by a proteomic analysis in a previous
study, proteins associated to rpL3 and/or to intron 3 tran-
script of the rpL3 gene, and we focused our studies on
proteins involved in RNA processing as putative compo-
nents of a RNP complex including rpL3 and mediating
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alternative splicing of the rpL3 pre-mRNA. Mass spec-
trometry results from GST pull-down experiments using
GST-rpL3 as bait demonstrated that NPM is one of
the proteins able to interact with rpL3 in vitro.
Conversely, KHSRP was not found associated to rpL3.
However, data obtained from RNA pull-down experi-
ments indicate that KHSRP is able to interact with the
intron 3 transcript of the rpL3 gene (15). Thus, we asked
whether NPM and KHSRP could be part of a RNP
complex including rpL3 through a direct or indirect inter-
action in vivo, by performing co-immunoprecipitation
assays.
Figure 1 shows the results of the experiments in which
NPM and KHSRP were speciﬁcally immunoprecipitated
from HeLa cells extracts by using antibodies against the
endogenous proteins. Immunoprecipitated proteins were
separated by SDS–PAGE and the presence of NPM and
KHSRP was investigated by western blotting in the recip-
rocally immunoprecipitated complexes. The results of
these experiments showed that NPM and KHSRP were
coimmunoprecipitated, thus indicating that they can asso-
ciate in vivo. Furthermore, a speciﬁc signal for rpL3
appeared both in NPM as well as in KHSRP
immunocomplexes. These data suggest that rpL3 is able
to interact in vivo with both proteins. Since we have pre-
viously demonstrated that hnRNP H1 is found included in
a complex with rpL3 and is involved in the regulation of
rpL3 gene alternative splicing (15), we looked for hnRNP
H1 in NPM and KHSRP immunoprecipitated complexes.
The presence of signal for hnRNP H1 in both immunopre-
cipitates was consistent with a speciﬁc association between
NPM, KHSRP and hnRNP H1. A control
immunoprecipitate obtained with anti-IgG antibodies
did not give any signal, when probed with anti-NPM,
anti-KHSRP, anti-rpL3 or anti-hnRNP H1 (Figure 1);
for a further control, see Supplementary Figure S1. In
the light of these results, it is plausible to hypothesize
that NPM, KHSRP, hnRNP H1 and rpL3 are associated
in a single quaternary complex; alternatively, NPM and
KHSRP could be part of independent protein
complexes, including or not rpL3, to which they are re-
cruited through different combination of protein–protein
interactions.
In an attempt to deﬁne a RNP complex including rpL3,
we investigated protein–protein interactions that rpL3
protein partners may establish within the complex. To
this aim, we performed GST pull-down assays by using
puriﬁed recombinant proteins. His-tagged proteins were
tested for their ability to bind to immobilized
GST-tagged proteins. GST-tagged proteins, and GST as
control, were immobilized using GSH-sepharose beads
and incubated with puriﬁed His-tagged proteins.
Western blot analysis was performed on each pull-down
sample. Figure 2 shows that His-hnRNP H1 was present
in the pull-down preparation of GST-NPM, but not in
those of GST-rpL3 or GST; His-NPM was detected in
the pull-down preparations of GST-rpL3, GST-hnRNP
H1, but not in that of GST; and His-KHSRP was
revealed in the pull-down preparations of GST-rpL3 and
GST-hnRNP H1, but not in those of GST-NPM or GST.
These results indicate that although a direct interaction
between rpL3 and hnRNP H1 has not been observed,
rpL3 and hnRNP H1 are able to interact directly with
NPM and KHSRP, while NPM and KHSRP are not
able to interact directly in the in vitro assay. No inter-
action whatsoever was detected with GST-rpL7a used as
a further control (data not shown).
Interactions between KHSRP, NPM, hnRNP H1 and
the intron 3 transcript in vivo and in vitro
Mass spectral analysis of our previous RNA pull-down
experiments revealed that KHSRP was able to interact
with intron 3 transcript of rpL3 gene in vitro (15). To
conﬁrm this interaction in vivo, we performed RNA
afﬁnity immunoprecipitation experiments. We speciﬁcally
immunoprecipitated KHSRP, and hnRNP H1 as con-
trol, from HeLa cell extracts by using monoclonal
antibodies against the endogenous proteins and searched
for the intron 3 transcript in the RNA–protein immuno-
precipitate complex (Figure 3A). Ampliﬁcation of the
signal corresponding to the intron 3 of rpL3 transcript,
but not of rpL7a gene transcript, by RT–PCR indicated
that KHSRP was able to bind with rpL3 pre-mRNA. The
absence of signal in the immunoprecipitate with anti-IgG
conﬁrmed the validity of this assay.
Although NPM was not found associated to the intron
3 transcript in vitro previously (15), we wondered
whether this interaction can occur in vivo. To this aim,
we speciﬁcally immunoprecipitated NPM from HeLa
cell extracts by using monoclonal antibodies against
the endogenous NPM. Analysis of RNA extracted
from the immunoprecipitate complex demonstrates that
NPM is able to precipitate the intron 3 transcript
(Figure 3A).
Next, in order to establish whether one or more among
the identiﬁed proteins was able to interact directly with
intron 3 RNA, or whether additional factors were
required, we performed RNA pull-down experiments by
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Figure 1. In vivo binding of NPM, KHSRP, hnRNP H1 and rpL3.
NPM or KHSRP were speciﬁcally immunoprecipitated from HeLa
cells extracts with antibodies against the endogenous NPM and
KHSRP. Immunoprecipitates were separated by SDS–PAGE and
immunoblotted with antibodies versus the indicated proteins. Note
the absence of signal in IgG immunocomplex. Results illustrated in
Figures 1–6 are representative of three independently performed
experiments.
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using puriﬁed recombinant proteins. For this purpose, a
transcript corresponding to the entire intron 3 of the rpL3
gene was used as bait and incubated with the puriﬁed re-
combinant proteins His-hnRNP H1 (control), His-NPM
or His-KHSRP and His-rpL7a as a control RNA binding
protein (17). Then, RNA-associated proteins were eluted
and analyzed by western blotting with antibodies against
the endogenous hnRNP H1, NPM, KHSRP and rpL7a.
The presence of signals speciﬁc for NPM and KHSRP
indicated that these two proteins are able to recognize
and bind to sequences in the rpL3 intron 3 transcript
(Figure 3B).
KHSRP regulates the alternative splicing of rpL3
pre-mRNA
The identiﬁcation of a speciﬁc interaction of KHSRP with
rpL3 and intron 3 transcript prompted us to investigate a
possible role of KHSRP in the rpL3 gene splicing. To this
aim, we analyzed the effects of the alteration in the expres-
sion levels of KHSRP on the rpL3 RNA splicing pattern.
Increasing amounts of a DNA construct expressing
Flag-KHSRP were transiently transfected in HeLa cells.
Twenty-four hours after transfection, cells were treated
with CHX to stabilize the alternatively spliced isoform
of rpL3 mRNA and lysed. Cells extracts were tested for
the detection of Flag-KHSRP levels by western blotting
with anti-Flag antibodies (Supplementary Figure S2A).
Total RNA from the same cell extract was analyzed by
RT–PCR using speciﬁc primers to amplify canonical
(rpL3-c) or alternative (rpL3-a) isoform of rpL3 mRNA.
We observed an increase in the rpL3-a mRNA level
correlated, in a dose-dependent mode, with increasing
amount of KHSRP (Figure 4A). These data indicate
that KHSRP positively affects the selection of the
30-cryptic splicing site within the intron 3 transcript of
rpL3 gene. Thus, we investigated the possibility that
KHSRP could act as a component of rpL3 autoregulatory
loop. We used L3–8 cells, a PC12 Tet-Off cell line stably
transfected with a vector containing the human
rpL3-coding sequence fused to the hemagglutinin (HA)
epitope-coding sequence (14). L3–8 cells were transiently
transfected with the DNA construct expressing
Flag-KHSRP. We chose a dose of Flag-KHSRP that
would result in about a 50% increase of the rpL3 alterna-
tive isoform mRNA. Twenty-four hours after transfec-
tion, we treated cells with CHX and induced the
expression of HA-rpL3 by removing doxycycline from
medium. Cells were then lysed and analyzed for the pro-
duction of Flag-KHSRP and HA-rpL3 by western
blotting using anti-Flag and anti-HA antibodies, respect-
ively (Supplementary Figure S2B). Total RNA was
analyzed by RT–PCR using speciﬁc primers to amplify
rpL3-c or rpL3-a mRNAs (Figure 4B). As previously
demonstrated the expression of the HA-rpL3 protein
resulted in an increase of the alternative isoform mRNA
(14). The expression of exogenous KHSRP also caused an
increase in rpL3-a mRNA level. Of interest, the increase in
the rpL3-a mRNA caused by overexpression of KHSRP
was greater after the induction of HA-rpL3 (Figure 4B).
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KHSRP and rpL7a. WB of RNA pull-down experiments, using
adipic acid dehydrazide agarose beads coated with intron 3 transcript
or unrelated RNA (Ctr RNA) incubated with puriﬁed proteins
His-hnRNP H1, His-NPM, His-KHSRP and His-rpL7a.
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The effects of KHSRP on rpL3 splicing were also
investigated in condition of mRNA silencing. L3–8 cells
were treated with siRNA speciﬁc for KHSRP and, 24 h
after transfection, cells were treated with CHX and
HA-rpL3 production was induced by removing doxycyc-
line from culture medium. Cells were then lysed and
protein extracts were analyzed for the expression of
KHSRP and HA-rpL3 by western blotting using
anti-KHSRP and anti-HA antibodies, respectively. As
shown in Supplementary Figure S2C, the decrease of
KHSRP level was 70% compared to the protein
amount detected in the control lysates. To examine the
effects of the reduced production of KHSRP on the
splicing pattern of rpL3 pre-mRNA, we analyzed total
RNA extracted from the same samples by RT–PCR
using speciﬁc primers to amplify rpL3-c and rpL3-a
mRNAs. As expected, in cells overexpressing rpL3, we
observed an increased level of rpL3-a mRNA isoform.
However, in cells, in which KHSRP had been silenced,
rpL3 induced overexpression was less effective in
promoting the production of rpL3-a mRNA isoform
(Figure 4C).
hnRNP H1 role in KHSRP-mediated activity
Since hnRNP H1 (15) and KHSRP have a role in
promoting the alternative splicing of rpL3 gene, we
asked whether a cooperation between these two proteins
would occur and favor the selection of 30-cryptic splicing
site, or whether their functions were redundant. To clarify
this issue, we switched off the expression of the gene
encoding hnRNP H1 by using RNA interference. To
this purpose, siRNAs against hnRNP H1 were transiently
transfected in L3–8 cells. Twenty-four hours after trans-
fection, cells were treated with CHX, induced for
HA-rpL3 production and harvested; RNA and proteins
were extracted. Lysates from cells transfected with
siRNA or untransfected were probed with hnRNP H1
antibodies. As shown in Supplementary Figure S3A, the
residual level of hnRNP H1 was 20% of the protein
detected in the control lysates. To investigate the effects
of the reduced production of hnRNP H1 on the splicing
pattern of rpL3 pre-mRNA, we examined the level of
rpL3 mRNA isoforms using RT–PCR. Under normal
conditions of rpL3 expression, the depletion of hnRNP
H1 resulted in a relevant decrease (80%) of the alterna-
tive mRNA (rpL3-a) level compared to controls. In con-
ditions of hnRNP H1 removal, rpL3, although
overexpressed, failed to activate the selection of the
30-cryptic splicing site (Figure 5A). These data indicate
clearly that hnRNP H1 plays a crucial role in triggering
the alternative splicing reaction of rpL3 pre-mRNA.
Next, we investigated a possible involvement of hnRNP
H1 in KHSRP-mediated activity. To this aim, we analyzed
the effects of hnRNP H1 depletion and KHSRP
overexpression on rpL3 splicing reaction. L3–8 cells
were transiently co-transfected with siRNA speciﬁc for
hnRNP H1 and a DNA construct expressing
Flag-KHSRP. Twenty-four hours after transfection, cells
were treated with CHX, induced for HA-rpL3 expression,
and harvested. hnRNP H1 and KHSRP protein levels
were detected by western blotting (Supplementary Figure
S3B). RNA extracted from the same lysates was analyzed
by RT–PCR. The Figure 5B shows that when hnRNP H1
was depleted, the enforced expression of KHSRP did not
cause an increase of rpL3-a mRNA level, either in normal
conditions of rpL3 expression, or in rpL3 overproduction.
These ﬁndings indicate that the ability of KHSRP to in-
ﬂuence the splicing of rpL3 pre-mRNA is mediated by
hnRNP H1.
NPM controls the alternative splicing of rpL3 gene
To study the functional relevance of the interactions of
NPM with rpL3 and intron 3 RNA in the control of the
rpL3 pre-mRNA splicing, we overexpressed NPM in
HeLa cells. Increasing amounts of a DNA construct ex-
pressing HA-NPM were transiently transfected in HeLa
cells. Twenty-four hours after transfection, cells were
treated with CHX and lysed. The expression levels of
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the recombinant fusion protein were detected by western
blotting using anti-HA antibodies (Supplementary Figure
S4A). The pattern of the spliced rpL3 gene transcript was
monitored by RT–PCR by using speciﬁc primers to
amplify rpL3-c and rpL3-a isoforms of rpL3 mRNA. As
shown in Figure 6A, NPM overexpression caused a
dose-dependent decrease of rpL3-a mRNA amounts.
Next, to investigate the role of NPM in the context of
rpL3 autoregolatory loop, we performed experiments of
overexpression and RNAi-mediated silencing of NPM in
L3–8 cell line. Cells were transiently transfected with a
DNA vector expressing HA-NPM. We chose a dose of
HA-NPM that would result in about 50% decrease of
the rpL3-a mRNA isoform. Twenty-four hours after
transfection, cells were treated with CHX and induced
to express HA-rpL3. Cells were then lysed and analyzed
for the production of HA-NPM and HA-rpL3 by western
blotting by using anti-HA antibody (Supplementary
Figure S4B). Total RNA from the same samples was
analyzed by RT–PCR by using speciﬁc primers to
amplify rpL3-c and rpL3-a isoforms of rpL3 mRNA.
The overexpression of NPM resulted in a reduction in
the rpL3-a mRNA amount in normal conditions of rpL3
expression, and prevented the increasing of rpL3-a mRNA
level when rpL3 protein was overexpressed (Figure 6B).
To investigate the effects of NPM removal on rpL3 gene
splicing, NPM expression levels were reduced by transfect-
ing L3–8 cells with speciﬁc siRNA. Twenty-four hours
after transfection, cells were treated with CHX and
induced to express HA-rpL3. Protein extracts from cells
were tested for the production of HA-NPM and HA-rpL3
by western blotting (Supplementary Figure S4C). Total
RNA was analyzed by RT–PCR by using speciﬁc
primers to amplify rpL3-c and rpL3-a mRNA isoforms.
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In physiological conditions of rpL3 expression, following
NPM depletion, the production of rpL3-a mRNA
appeared restored above the control expressing NPM.
Thus, as expected, HA-rpL3 expression upon NPM
silencing caused a signiﬁcant increase of rpL3-a mRNA
levels (Figure 6C).
DISCUSSION
AS of mRNA is mainly responsible for a variety of gene
products much larger than expected from the number of
genes. It has been estimated that >90% of human genes
are alternatively spliced (18,19). However, a number of
splicing events give rise to mRNA isoforms containing a
PTC that are targeted for decay by NMD. Accumulating
data indicate that association of AS and NMD
(AS-NMD) may result in a quantitative post-
transcriptional regulation of gene expression (7).
In eukaryotes rp expression is regulated by multiple
control mechanisms, mostly at post-transcriptional and
translational level in order to maintain ribosome biosyn-
thesis at the level appropriate to growth conditions and
requirements of the cell (14,15,20,21). However, several
reports indicate that rp, in addition to the role as compo-
nents of the translation machinery, exert a variety of
extraribosomal functions, for which additional, speciﬁc
regulatory strategies are required (22,23). Autoregulation
may represent an efﬁcient mechanism to control the level
of a single protein; we have demonstrated previously a role
of AS-NMD in the regulation of the rpL3 gene expression,
promoted by rpL3 protein itself as part of an
autoregulatory negative-feedback loop (14,15).
In an attempt to understand the mechanism of the regu-
latory strategy, we focused our studies on the identiﬁca-
tion of protein partners of the rpL3 protein, and to the
analysis of their contribution to the process. Our previous
results demonstrated that rpL3 protein, within a RNP
complex including the constitutive splicing factor
hnRNP H1, promotes the alternative splicing reaction of
its own gene (15). In most cases, the choice of a splicing
site is made by a dynamic and complex combination of
different splicing regulators; in fact, the function of an
individual splicing factor may be different depending on
interacting partners present in the regulatory network.
The identiﬁcation of new regulatory proteins and the
mapping of protein–protein interactions within the RNP
complex including rpL3 are crucial steps to understand
the molecular mechanism involved in the selection of the
cryptic 30-splice site within intron 3 transcript of the rpL3
gene. To this aim, we analyzed occurrence of interaction
between rpL3 and putative protein partners previously
identiﬁed through a proteomic analysis (15), and the role
of these proteins in the autoregulatory network of rpL3
expression. Our data provide an insight in putative RNP
complexes including hnRNP H1, rpL3 protein,
pre-mRNA of rpL3 gene, and the newly identiﬁed
protein factors, NPM and KHSRP, involved in the regu-
lation of rpL3 gene expression via AS-NMD.
NPM is a nucleolar, ubiquitous and multifunctional
phosphoprotein. NPM is involved in multiple biological
functions including the ribosome biogenesis, the control of
cell cycle progression and centrosome duplication. The
cellular activities of NPM are tightly regulated by
multiple factors that seem to be speciﬁc for each
function. Post-translational modiﬁcations, oligomeriza-
tion and hetero-oligomerization strongly inﬂuence the
cellular functions of NPM (24). Emerging evidences
indicate a functional correlation between NPM and
some rp, independent from ribosome biogenesis or its
assembly (25,26). It is known that NPM is involved in
both positive and negative regulation of transcription,
and a possible role of NPM in the splicing process has
been suggested (27). To our knowledge, the present
study demonstrates for the ﬁrst time a role of NPM as
splicing factor.
KHSRP is a multifunctional RNA-binding protein that
has been mainly implicated in post-transcriptional regula-
tion, mRNA decay and maturation of microRNA precur-
sors (28,29). There are few data supporting an
involvement of KHSRP in the splicing control (30,31).
Analysis of immunoprecipitate of NPM and KHSRP in
HeLa cell extracts showed that NPM and KHSRP
coimmunoprecipitate together with rpL3 and hnRNP
H1, indicating that these proteins associate in vivo,
although the occurrence of multiple complexes including
different combination of protein interactions cannot be
excluded (Figure 1). In addition, in vitro GST pull-down
experiments (Figure 2) demonstrated that NPM and
KHSRP are able to recognize and bind rpL3 and
hnRNPH1, whereas a direct binding between NPM
and KHSRP, or rpL3 and hnRNPH1 has not been
observed.
On the other hand, RNA immunoprecipitation assays
indicated the presence of intron 3 RNA in the
immunoprecipitate of NPM and KHSRP, and RNA
pull-down experiments showed that NPM and KHSRP
are able to contact directly the intron 3 RNA (Figure 3)
as previously shown for hnRNP H1 (15). Taken together,
these data strongly suggest that NPM and KHSRP are
involved in the control of the splicing of rpL3.
Our analysis of the effects of individual expression of
NPM, hnRNP H1 or KHSRP provided an insight also on
the speciﬁc role of each protein factor on the rpL3 gene
splicing. In the context of rpL3 autoregulatory circuit,
protein overexpression data indicated that KHSRP repre-
sents a positive regulator of the alternative splicing that
cooperates with rpL3 and hnRNP H1 in the activation of
30-cryptic splice site (Figure 4). However, silencing of
KHSRP caused only 20% decrease of the alternative
mRNA isoform produced when rpL3 is overexpressed,
suggesting that KHSRP is not a crucial player in the
rpL3 autoregulatory loop (Figure 4). Instead, when
hnRNPH1 expression was silenced, rpL3 overexpression
failed to result in the activation of cryptic the 30-splice site
(Figure 5A). These ﬁndings together with the observation
that KHSRP, even in excess, was unable to increase the
alternative mRNA isoform in the absence of hnRNP H1
strongly indicate that hnRNP H1 is the key component of
rpL3 autoregulatory loop, while KHSRP might play a role
as an enhancer of hnRNP H1-mediated activation of rpL3
gene alternative splicing (Figure 5B).
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It is known that the RNA binding activity of KHSRP is
mediated by four KH domains. Among these, KH1 and
KH3 domains recognize and bind speciﬁcally to a G-rich
target (UGGG and GGGU, respectively) (32). The
analysis of the human intron 3 transcript sequence
showed that G6 motif, an essential element for the
splicing regulatory activity of hnRNP H1, could represent
also a binding site for KH1 or KH3. In addition, the
UGCAUG element, essential to the binding of KHRSP
to src-DCS (Downstream Control Sequence), is also
present in the sequence of intron 3 RNA and it is
located close to the hnRNP H1 binding site G3 and G6
motifs (31). Consequently, it seems plausible to speculate
that KHSRP might interact with these sequences within
intron 3 transcript as well as with hnRNP H1 making
more stable and efﬁcient the association of hnRNP H1
with intron 3 RNA.
Unlike hnRNP H1 and KHSRP, NPM behaves as a
negative regulatory factor of rpL3 gene alternative
splicing (Figure 6). It is possible that the inhibitory
effect of NPM on alternative splicing might be due to a
‘bind and block’ mechanism. In fact, NPM could interact
with sequences within intron 3 pre-mRNA, perhaps in the
vicinity of hnRNP H1 binding sites, and sterically block
the access of hnRNP H1, thus preventing its interaction
with G3 and G6 elements. Since binding of hnRNP H1 to
G-runs site has been demonstrated crucial, the alternative
splicing of rpL3 gene would be negatively affected.
Alternatively, in the light of results demonstrating an
interplay among different protein factors, possibly
assembled in multiple RNP complexes, we propose a
working model, which overcomes the model proposed pre-
viously (15). The model predicts the existence of, at least,
two complexes whose protein composition depends on
rpL3 protein levels. When cell functions require an efﬁ-
cient production of rpL3, the interaction of NPM with
intron 3 pre-mRNA might affect its secondary structure
and mask the binding sites of hnRNP H1. At the same
time, repression of AS might be enforced by a concomi-
tant direct binding of NPM to the positive regulator factor
hnRNP H1 (Figure 7A).
When rpL3 levels exceed cell requirements for rpL3
ribosomal as well as extraribosomal functions, the
protein could interact with NPM; consequently, NPM
would be released from the RNP complex to which rpL3
could be associated by interacting with KHSRP. The
removal of NPM, and the rearrangement of the inter-
actions within the RNP complex, could make available
the enhancer unit G3+G6 within intron 3 transcript
and, at the same time, the presence of rpL3 in the re-
modeled complex could induce conformational changes
that favor the interaction of hnRNP H1 with G3+G6.
Finally, such complex could promote the activation of
the alternative mode of splicing reaction (Figure 7B).
At the present, the challenge is to determine the hier-
archy of interactions leading to the assembly of RNP
complexes, and the dynamic nature of protein–protein
interactions causing the remodeling of complexes respon-
sible for the modulation of the splicing of the rpL3 gene.
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